Neuropsychological change in patients with schizophrenia after treatment with quetiapine or haloperidol.

OBJECTIVE: To assess the efficacy of quetiapine, a recently introduced second generation antipsychotic medication, in reducing cognitive impairment in patients with schizophrenia. DESIGN: Prospective, randomized, double-blind clinical trial. PATIENTS: 25 patients who met the Diagnostic and Statistic...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Purdon, S E, Malla, A, Labelle, A, Lit, W
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: 2001
Onderwerpen:
Research Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC1407745/
https://ncbi.nlm.nih.gov/pubmed/11291531
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items